Usefulness of the rK39-immunochromatographic test, direct agglutination test, and leishmanin skin test for detecting asymptomatic Leishmania infection in children in a new visceral leishmaniasis focus in Amhara State, Ethiopia

American Journal of Tropical Medicine and Hygiene

Volumn 86, Issue 5, 2012, Pages 792-798

  Gadisa, Endalamaw ^a   Custodio, Estefanía ^b   Cañavate, Carmen ^c   Sordo, Luis ^d   Abebe, Zelalem ^e   Nieto, Javier ^c   Chicharro, Carmen ^c   Aseffa, Abraham ^a   Yamuah, Lawrence ^a   Engers, Howard ^a   Moreno, Javier ^c   Cruz, Israel ^c  

^a All Africa Leprosy Tuberculosis and Rehabilitation Training Centre Addis Ababa   (Ethiopia)

^b Red de Investigación de Centros de Enfermedades Tropicales RICET Madrid   (Spain)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d CARLOS III INSTITUTE OF HEALTH   (Spain)

^e Amhara Regional State Research Laboratory   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGGLUTINATION TEST; ARTICLE; ASYMPTOMATIC INFECTION; CHILD; ENDEMIC DISEASE; ETHIOPIA; FEMALE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; LEISHMANIN SKIN TEST; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RURAL AREA; RURAL POPULATION; SCHOOL CHILD; SEROLOGY; VISCERAL LEISHMANIASIS;

ADOLESCENT; AGGLUTINATION TESTS; ANTIGENS, PROTOZOAN; ASYMPTOMATIC INFECTIONS; CHILD; CHILD, PRESCHOOL; ENDEMIC DISEASES; ETHIOPIA; FEMALE; HUMANS; IMMUNOCHROMATOGRAPHY; LEISHMANIA; LEISHMANIASIS, VISCERAL; MALE; SKIN TESTS;

EID: 84861826033     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.11-0196     Document Type: Article

References (38)

1. Desjeux P, 2004. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27: 305-318.
2. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, Alvar J, Bolaert M, 2007. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5: 873-882.
3. Yamey G, Torreele E, 2002. The world's most neglected diseases. BMJ 325: 176-177.
4. Dujardin JC, 2006. Risk factors in the spread of leishmaniases: towards integrated monitoring? Trends Parasitol 22: 4-6.
5. Berman JD, 1997. Human leishmaniasis: clinical, diagnostic and chemotherapeutic developments in the last 10 years. Clin Infect Dis 24: 684-703.
6. Herrero M, Orfanos G, Argaw D, Muguleta A, Aparicio P, Parreño F, Bernal O, Rubens D, Pedraza J, Lima MA, Flevaud L, Palma PP, Bashaye S, Alvar J, Bern C, 2009. Natural history of a visceral leishmaniasis outbreak in Highland Ethiopia. Am J Trop Med Hyg 81: 373-377.
7. Topno RK, Das VN, Ranjan A, Pandey K, Singh D, Kumar N, Siddiqui NA, Singh VP, Kesari S, Kumar N, Bimal S, Kumar AJ, Meena C, Kumar R, Das P, 2010. Asymptomatic infection with visceral leishmaniasis in a diseases-endemic area in Bihar, India. Am J Trop Med Hyg 83: 502-506.
8. Costa CH, Stewart JM, Gomes RB, Garcez LM, Ramos PK, Bozza M, Satoskar A, Dissanayake S, Santos RS, Silva MR, Shaw JJ, David JR, Maguire JH, 2002. Asymptomatic human carriers of Leishmania chagasi. Am J Trop Med Hyg 66: 334-337.
9. Schenkel K, Rijal S, Koirala S, Koirala S, Vanlerberghe V, Van der Stuyft P, Gramiccia M, Boelaert M, 2006. Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors. Trop Med Int Health 11: 1792-1799.
10. Sundar S, Maurya R, Singh RK, Bharti K, Chakravarty J, Parekh A, Rai M, Kumar K, Murray HW, 2006. Rapid, noninvasive diagnosis of visceral leishmaniasis in India: comparison of two immunochromatographic strip tests for detection of anti-K39 antibody. J Clin Microbiol 44: 251-253.
11. Riera C, Fisa R, López-Chejade P, Serra T, Girona E, Jiménez MT, Muncunill J, Sedeño M, Mascaró M, Udina M, Gá llego M, Carrió J, Forteza A, Portú s M, 2008. Asymptomatic infection by Leishmania infantum in blood donors from the Balearic Islands (Spain). Transfusion 48: 1383-1389.
12. Romero HD, Silva LA, Silva-Vergara ML, Rodrigues V, Costa RT, Fernandes Guimarães S, Alecrim W, Moraes-Souza H, Prata A, 2009. Comparative study of serologic tests for the diagnosis of asymptomatic visceral leishmaniasis in an endemic area. Am J Trop Med Hyg 81: 27-33.
13. Zijlstra EE, El-Hassan AM, Ismael A, Ghalib HW, 1994. Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. Am J Trop Med Hyg 51: 826-836.
14. Khalil EA, Ayed NB, Musa AM, Ibrahim ME, Mukhtar MM, Zijlstra EE, Elhassan IM, Smith PG, Kieny PM, Ghalib HW, Zicker F, Modabber F, Elhassan AM, 2005. Dichotomy of protective cellular immune responses to human visceral leishmaniasis. Clin Exp Immunol 140: 349-353.
15. Alvar J, Bashaye S, Argaw D, Cruz I, Aparicio P, Kassa A, Orfanos G, Parreño F, Babaniyi O, Gudeta N, Cañavate C, Bern C, 2007. Kala-azar outbreak in Libo Kemkem, Ethiopia: epidemiologic and parasitologic assessment. Am J Trop Med Hyg 77: 275-282.
16. Gidwani K, Rai M, Chakravarty J, Bolaert M, Sundar S, 2009. Evaluation of leishmanin skin test in Indian visceral leishmaniasis. Am J Trop Med Hyg 80: 566-567.
17. De Gouvêa Viana L, De Assis TS, Orsini M, da Silva AR, De Souza GF, Caligiorne R, Da Silva AC, Peruhype-Magalhaes V, Vieira Marciano AP, Martins-Filho OA, Rabello A, 2008. Combined diagnostic methods identify a remarkable proportion of asymptomatic Leishmania (Leishmania) chagasi carriers who present modulated cytokine profiles. Trans R Soc Trop Med Hyg 102: 548-555.
18. Biglino A, Bolla C, Concialdi E, Trisciuoglio A, Romano A, Ferroglio E, 2010. Asymptomatic Leishmania infantum infection in an area of northwestern Italy (Piedmont Region) where such infections are traditionally nonendemic. J Clin Microbiol 48: 131-136.
19. Barao SC, De Fonseca Camargo-Neves VL, Resende MR, Da Silva LJ, 2007. Human asymptomatic infection in visceral leishmaniasis: a seroprevalence study in an urban area of low endemicity. Preliminary results. Am J Trop Med Hyg 77: 1051-1053.
20. Alvar J, Aparicio P, Aseffa A, Den Boer M, Cañavate C, Dedet JP, Gradoni L, Ter Horst R, López-Vélez R, Moreno J, 2008. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21: 334-359.
21. Burki T, 2009. East African countries struggle with visceral leishmaniasis. Lancet 374: 371-372.
22. Alvar J, Cañavate C, Gutiérrez-Solar B, Jiménez M, Laguna F, López-Vélez R, Molina R, Moreno J, 1997. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 10: 298-312.
23. Elnaiem DA, Connor SJ, Thomson MC, Hassan MM, Hassan HK, Aboud MA, Ashford RW, 1998. Environmental determinants of the distribution of Phlebotomus orientalis in Sudan. Ann Trop Med Parasitol 92: 877-887.
24. Gebre-Michael T, Balkew M, Alamirew T, Gudeta N, Reta M, 2007. Preliminary entomological observations in a highland area of Amhara region, northern Ethiopia, with epidemic visceral leishmaniasis. Ann Trop Med Parasitol 101: 367-370.
25. El-Safi SH, Bucheton B, Kheir MM, Musa HA, El-Obaid M, Hammad A, Dessein A, 2002. Epidemiologyof visceral leishmaniasis in Atbara River area, eastern Sudan: the outbreak of Barbar el Fugara village (1996-1997). Microbes Infect 4: 1439-1447.
26. Hailu A, Gramiccia M, Kager PA, 2009. Visceral leishmaniasis in Aba Roba, south-western Ethiopia: prevalence and incidence of active and subclinical infections. Ann Trop Med Parasitol 103: 659-670.
27. Mahmoodi M, Khamesipour A, Dowlati Y, Rafati S, Momeni A, Emamjomeh M, Hejazi H, Modabber F, 2003. Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG. Clin Exp Immunol 134: 303-308.
28. Sinha PK, Bimal S, Pandey K, Singh SK, Ranjan A, Kumar N, Lal CS, Barman SB, Verma RB, Jeyakumar A, Das P, Bhattacharya M, Sur D, Bhattacharya SK, 2008. A community-based, comparative evaluation of direct agglutination and rK39 strip tests in the early detection of subclinical Leishmania donovani infection. Ann Trop Med Parasitol 102: 119-125.
29. Gidwani K, Kumar R, Rai M, Sundar S, 2009. Longitudinal seroepidemiologic study of visceral leishmaniasis in hyperendemic regions of Bihar, India. Am J Trop Med Hyg 80: 345-346.
30. Manson-Bahr PE, 1961. Immunity in kala-azar. Trans R Soc Trop Med Hyg 55: 550-555.
31. Evans TG, Teixeira MJ, McAuliffe IT, Vasconcelos I, Vasconcelos AW, Sousa AA, Lima JW, Pearson RD, 1992. Epidemiology of visceral leishmaniasis in northeast Brazil. J Infect Dis 166: 1124-1132.
32. Riera C, Fisa R, Udina M, Gá llego M, Portú s M, 2004. Detection of Leishmania infantum cryptic infection in asymptomatic blood donors living in an endemic area (Eivissa, Balearic Islands, Spain) by different diagnostic methods. Trans R Soc Trop Med Hyg 98: 102-110.
33. Ritmeijer K, Melaku Y, Mueller M, Kipngetich S, O'Keeffe C, Davidson RN, 2006. Evaluation of a new recombinant K39 rapid diagnostic test for Sudanese visceral leishmaniasis. Am J Trop Med Hyg 74: 76-80.
34. Chappuis F, Rijal S, Soto A, Menten J, Boelaert M, 2006. A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ 333: 723.
35. Cañ avate C, Herrero M, Nieto J, Cruz I, Chicharro C, Aparicio P, Mulugeta A, Argaw D, Blackstock AJ, Alvar J, Bern C, 2011. Evaluation of two rK39 dipstick tests, direct agglutination test, and indirect fluorescent antibody test for diagnosis of visceral leishmaniasis in a new epidemic site in highland Ethiopia. Am J Trop Med Hyg 84: 102-106.
36. Boelaert M, Rijal S, Regmi S, Singh R, Karki B, Jacquet D, Chappuis F, Campino L, Desjeux P, Le Ray D, Koirala S, Van der Stuyft P, 2004. A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis. Am J Trop Med Hyg 70: 72-77.
37. Ter Horst R, Tefera T, Assefa G, Ebrahim AZ, Davidson RN, Ritmeijer K, 2009. Field evaluation of rK39 test and direct agglutination test for diagnosis of visceral leishmaniasis in a population with high prevalence of human immunodeficiency virus in Ethiopia. Am J Trop Med Hyg 80: 929-934.
38. Zijlstra EE, Daifalla NS, Kager PA, Khalil EA, El-Hassan AM, Reed SG, Ghalib HW, 1998. rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection. Clin Diagn Lab Immunol 5: 717-720.